Allergy/Asthma/Immunology

Top Story

Prenatal vitamin D supplementation failed to prevent asthma in at-risk children

February 7, 2020
FDA News

FDA approves Palforzia, first peanut allergy treatment for children

February 3, 2020
The FDA announced that it approved the oral immunotherapy Palforzia, the first treatment for peanut allergy in children aged 4 to 17 years. According to the FDA and the…
Pharmacology Consult

New biologic drugs for asthma: What PCPs need to know

Infectious Diseases in Children, January 2020
Edward A. Bell, PharmD, BCPS
In recent years, we have made significant strides in our understanding of the pathogenesis of asthma. As a result, specific new pharmacotherapies and therapeutic…
In the Journals

Top 10 most-read Infectious Diseases in Children stories of 2019

January 2, 2020
To kick off the new year, IDC has assembled a list of the 10 most-read stories of 2019. Please follow the links to access the full stories.  
More Headlines »
Special Issue Article

Angioedema

Pediatric Annals, December 2019, Volume 48 Issue 12
Angioedema is a localized swelling of the skin and submucosal tissues and is generally benign and self-limiting…
More »
CME

Asthma Insights: Treating by Phenotype and Improving Adherence to Treatment

This educational activity is supported by an educational grant from GlaxoSmithKline.

More »
Video
Meeting News

VIDEO: New early peanut introduction guidelines must undo ‘years of misconceptions’

October 28, 2017
More »